Fredric P. Manfredsson,Jack W. Lipton,Nicholas Kanaan,Timothy Collier,Kathy Steece-Collier,Caryl E. Sortwell
申请号：
US15316726
公开号：
US10144932B2
申请日:
2015.06.05
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Methods of treating movement disorders by reducing the activity of Nurr1 are disclosed. These methods are particularly applicable to subjects suffering from Parkinsons disease who have either developed levodopa-induced dyskinesia (LID) or are at risk of developing LID. In some aspects, the invention relates to a method for treating a movement disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a composition, wherein said composition reduces the activity of a nuclea receptor related 1 protein (“Nurr1”). In some embodiments, the movement disorder is a dyskinesia. The movement disorder may be a levodopa-induced dyskinesia.
